$1.52 Billion is the total value of Empyrean Capital Partners, LP's 57 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGN | ALLERGAN PLC | $243,455,000 | +13.6% | 1,273,500 | 0.0% | 16.01% | +43.6% | |
SRG | SERITAGE GROWTH PPTYScl a | $100,200,000 | -5.7% | 2,500,000 | 0.0% | 6.59% | +19.2% | |
PLYA | PLAYA HOTELS & RESORTS NV | $47,166,000 | +7.3% | 5,615,000 | 0.0% | 3.10% | +35.6% | |
TFSL | TFS FINL CORP | $35,205,000 | +9.2% | 1,788,868 | 0.0% | 2.32% | +38.0% | |
ATLAS AIR WORLDWIDE HLDGS INnote 1.875% 6/0 | $34,000,000 | +2.1% | 40,000,000 | 0.0% | 2.24% | +29.0% | ||
LSXMK | LIBERTY MEDIA CORP DELAWARE | $31,870,000 | +14.7% | 662,029 | 0.0% | 2.10% | +45.0% | |
VISHAY INTERTECHNOLOGY INCnote 2.250% 6/1 | $26,013,000 | +6.3% | 26,000,000 | 0.0% | 1.71% | +34.3% | ||
PRA GROUP INCnote 3.500% 6/0 | $23,468,000 | +3.1% | 22,471,000 | 0.0% | 1.54% | +30.3% | ||
LSXMA | LIBERTY MEDIA CORP DELAWARE | $21,173,000 | +16.3% | 438,000 | 0.0% | 1.39% | +47.0% | |
CALAMP CORPnote 2.000% 8/0 | $16,588,000 | +1.6% | 20,000,000 | 0.0% | 1.09% | +28.5% | ||
LTRPA | LIBERTY TRIPADVISOR HLDGS IN | $15,940,000 | -21.9% | 2,168,753 | 0.0% | 1.05% | -1.2% | |
TEAM INCnote 5.000% 8/0 | $9,945,000 | -5.6% | 9,500,000 | 0.0% | 0.65% | +19.3% | ||
SPLUNK INCnote 0.500% 9/1 | $6,019,000 | +11.7% | 5,000,000 | 0.0% | 0.40% | +41.4% | ||
OPKO HEALTH INCnote 4.500% 2/1 | $5,469,000 | -4.7% | 7,000,000 | 0.0% | 0.36% | +20.4% | ||
CLOVIS ONCOLOGY INCnote 1.250% 5/0 | $4,320,000 | +52.0% | 6,750,000 | 0.0% | 0.28% | +91.9% | ||
ZILLOW GROUP INCnote 2.000%12/0 | $3,918,000 | +12.6% | 3,500,000 | 0.0% | 0.26% | +42.5% | ||
REDWOOD TR INCnote 5.625% 7/1 | $3,321,000 | +0.4% | 3,250,000 | 0.0% | 0.22% | +26.7% | ||
LFAC | LF CAP ACQUISITION CORPcl a | $1,487,000 | +0.8% | 143,800 | 0.0% | 0.10% | +27.3% | |
ENVA | ENOVA INTL INC | $1,203,000 | +15.9% | 50,000 | 0.0% | 0.08% | +46.3% | |
MNCLW | MONOCLE ACQUISITION CORP*w exp 12/06/202 | $150,000 | +63.0% | 200,000 | 0.0% | 0.01% | +100.0% | |
FMCIW | FORUM MERGER II CORP*w exp 09/30/202 | $92,000 | -22.0% | 200,000 | 0.0% | 0.01% | 0.0% | |
MFACWS | MEGALITH FINL ACQUISITION CO*w exp 08/26/202 | $64,000 | -15.8% | 200,000 | 0.0% | 0.00% | 0.0% | |
NFINW | NETFIN ACQUISITION CORP*w exp 08/01/202 | $60,000 | 0.0% | 200,000 | 0.0% | 0.00% | +33.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TFS FINL CORP | 37 | Q2 2022 | 4.2% |
LIBERTY TRIPADVISOR HLDGS IN | 35 | Q3 2023 | 4.4% |
ENOVA INTL INC | 31 | Q3 2023 | 3.3% |
NOVAGOLD RES INC | 31 | Q3 2023 | 2.5% |
LIBERTY MEDIA CORP DELAWARE | 29 | Q2 2023 | 2.1% |
LIBERTY MEDIA CORP DELAWARE | 29 | Q2 2023 | 1.4% |
SPDR S&P 500 ETF TR | 28 | Q1 2023 | 39.9% |
SERITAGE GROWTH PPTYS | 22 | Q4 2020 | 6.6% |
CURO GROUP HOLDINGS CORP | 22 | Q1 2023 | 1.8% |
ATLAS AIR WORLDWIDE HLDGS IN | 21 | Q2 2022 | 2.2% |
View Empyrean Capital Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Altus Power, Inc. | February 14, 2023 | 516,127 | 0.3% |
Athlon Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
Austerlitz Acquisition Corp ISold out | February 14, 2023 | 0 | 0.0% |
Churchill Capital Corp V | February 14, 2023 | 3,845,200 | 7.7% |
Crucible Acquisition CorpSold out | February 14, 2023 | 0 | 0.0% |
CURO Group Holdings Corp. | February 14, 2023 | 1,900,000 | 4.7% |
Cyxtera Technologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Deep Lake Capital Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
eFFECTOR Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Fifth Wall Acquisition Corp. III | February 14, 2023 | 2,299,000 | 8.1% |
View Empyrean Capital Partners, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
View Empyrean Capital Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.